Home page > Medicines, health technology and health information

prevention


Please find all related articles below.



Transatlantic Trade and Investment Partnership International Trade Law, Health Systems and Public Health


Free trade agreements (FTAs) have the declared aim of seeking to increase global trade and promote economic growth. Historically, economic growth has led to improved population health. Yet this link is now weakening, and attention is being focussed on assessing the effect of FTAs on health and the ability of government to mitigate against negative impact. Within this context, this study presents an assessment of the health impact of the proposed FTA between the United States and the (...)
10/02/2015

[Event report] HEPAMAP: A Roadmap for EU Liver Research


On 10 December 2014, in an event hosted by MEP Cristian Buşoi (EPP, RO) in the European Parliament, the European Association for the Study of the Liver (EASL) launched the ‘Research Roadmap for Liver Disease (HEPAMAP) - Case study for chronic diseases & research’. The HEPAMAP stresses the need for further research on liver disease and calls on policy makers to step up their efforts to tackle the disease and its links with lifestyle and other diseases, such as (...)
30/01/2015

Regulation on Endocrine Disrupting Chemicals: an opportunity to stop cancer before it starts


On 7 January, a meeting on ‘Regulation on Endocrine Disrupting Chemicals: an opportunity to stop cancer before it starts’ was held in the European Parliament, where MEPs, civil society organisations, and academics called for better regulation on Endocrine Disrupting Chemicals (EDC). MEPs began the session, represented by Alojz Peterle (EPP, Slovenia), Pavel Poc (S&D, Czech Rep.) and Christel Schaldemose (S&D, Denmark). Mr Peterle pointed out that cancer is no longer (...)
26/01/2015

Air Pollution: Are EU Policy Makers Aware of the Danger for Public Health?


While experts highlight the health effects and economic costs of air pollution, the European Commission is planning to amend the air quality proposal which is likely to have significant benefits for health right across Europe. In considering modifications to the EU clean air package, the European Commission has an opportunity to promote prevention and to consider people’s health. Parliament Hearing to present scientific evidence on EU air quality policy At the public hearing (...)
17/12/2014

[EASL Press Release] Liver disease in Europe: new study reveals pressing need to focus on research and policy action


Brussels, 10 December 2014 – Today, in an event hosted by MEP Cristian Buşoi (EPP, RO) in the European Parliament, the European Association for the Study of the Liver (EASL) (1) launched the ‘Research Roadmap for Liver Disease (HEPAMAP) - Case study for chronic diseases & research’ (2). The HEPAMAP stresses the need for further research on liver disease and calls on policy makers to step up their efforts to tackle the disease and its links with lifestyle and other (...)
10/12/2014

[EPHA Professional Development Programme - Autumn 2014] EU health advocacy training


In Brussels on 8th/9th/10th December 2014, EPHA will launch the first part of its 7th Professional Development Programme (PDP). The Autumn 2014 programme aims to train those new to the ‘EU bubble’ to get an introduction to key issues around public health advocacy in the EU. EPHA PDP provides a chance for young professionals working primarily in health-related organisations or civil society organisations to gain a better understanding of: How to campaign successfully through (...)
21/11/2014

[ECC Press statement] World COPD Day 2014: Why a disease that affects one in ten adults in Europe is still neglected?


Brussels, 19 November 2014 - Chronic Obstructive Pulmonary Disease (COPD) (1) affects up to 10% of European adults and is the fourth cause of death worldwide and is expected to be in third place by 2030 (2). As yet, few EU leaders or policy-makers are aware of this fact. Until this changes, little political action will be given to tackle one of the most acute public health issues in Europe. “As a first step to effectively address this public health threat, we should get much better (...)
19/11/2014

[Save the date] Launch: Research Roadmap for Liver Disease - 10 December (15.00 – 17.00), Brussels


MEP Cristian Buşoi (EPP, RO) has the pleasure to invite you to the ‘Launch of a Research Roadmap for Liver Disease (HEPAMAP) - Case study for chronic diseases & research’, A European Parliament seminar organised in collaboration with the European Association for the Study of the Liver (EASL). 10 December 2014, 15.00 – 17.00 | Venue: The European Parliament, Alteiro Spinell (Brussels). Room: A3F383 Launch of a Research Roadmap for Liver Disease (HEPAMAP) - (...)
17/11/2014

Scottish Industry Representatives Support Scotland’s brave Alcohol Policy


On 5 September 2014, following the EPHA Annual Conference, the seminar on Scotland’s innovative Alcohol Policies successfully brought together representatives from Scottish health professionals with around 80 European colleagues and industry representatives to discuss the minimum unit pricing (MUP). This event highlighted the fact that different stakeholders are urging EU Member States and the European Commission to support the Scottish policy on alcohol. MUP is opposed by a (...)
31/10/2014

[Press release] The European Parliament will not gain people’s trust by continuing to contribute to the burden of chronic disease in the form of tobacco subsidies


Brussels, 23 October 2014 – Among all the furore yesterday of the new Commission, the European Parliament also quietly voted against ending EU subsidies to tobacco crops (1). While on the one hand many MEPs so supportive of legislating in favour of health with regards to pharmaceutical products, it seems that over half of the EP is happy to continue pumping taxpayer’s money to a harmful industry (2) instead of supporting farmers to make the shift to a more health and sustainable (...)
23/10/2014